Polymersomes from polypeptide containing triblock co- and terpolymers for drug delivery against pancreatic cancer: Asymmetry of the external hydrophilic blocks

Macromolecular Bioscience

Volumn 14, Issue 9, 2014, Pages 1222-1238

  Iatrou, Hermis ^a   Dimas, Konstantinos ^b   Gkikas, Manos ^a   Tsimblouli, Chrisida ^b   Sofianopoulou, Sosanna ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c Ministry of Rural Development and Food   (Greece)

Author keywords

Nanoparticles; Nanotechnology; Pancreatic cancer; Polymersomes; Polypeptides

Indexed keywords

AMINO ACIDS; CELL CULTURE; CONTROLLED DRUG DELIVERY; DISEASES; ETHYLENE; HYDROPHILICITY; NANOPARTICLES; NANOTECHNOLOGY; PHASE LOCKED LOOPS; POLYETHYLENE OXIDES; POLYPEPTIDES; DRUG DELIVERY;

AMPHIPHILIC POLYMERS; HYDROPHILIC BLOCKS; L-LYSINE HYDROCHLORIDE; OUTER PERIPHERY; PANCREATIC CANCERS; PH-DEPENDENT; POLY (ETHYLENE OXIDE) (PEO); POLYMERSOMES;

TARGETED DRUG DELIVERY; POLYMERS;

AMPHOPHILE; BIOMATERIAL; DOXORUBICIN; NANOCARRIER; NANOPARTICLE; PACLITAXEL; POLY(ETHYLENE OXIDE) B POLY(GAMMA BENZYL GLUTAMATE) B POLY(LYSINE HYDROCHLORIDE); POLY(LYSINE HYDROCHLORIDE) B POLY(GAMMA BENZYL (D7) GLUTAMATE) B POLY(LYSINE HYDROCHLORIDE); POLYMER; UNCLASSIFIED DRUG; POLYPEPTIDE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DRUG CARRIER; MACROGOL DERIVATIVE; POLY-GAMMA-BENZYL-L-GLUTAMATE; POLYGLUTAMIC ACID; POLYLYSINE;

ADENOCARCINOMA CELL LINE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED DRUG RELEASE; CYTOTOXICITY; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; HYPOACTIVITY; LOADING DRUG DOSE; MALE; MOLECULAR WEIGHT; MOUSE; NANOENCAPSULATION; NONHUMAN; PANCREAS CANCER; PANCREATIC CANCER CELL LINE; PH; POLYMERIZATION; TEMPERATURE DEPENDENCE; TOXICITY TESTING; ZETA POTENTIAL; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; PHYSICAL CHEMISTRY; TEMPERATURE; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG SCREENING; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; SYNTHESIS; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NANOPARTICLES; PACLITAXEL; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; POLYGLUTAMIC ACID; POLYLYSINE;

EID: 84908022222     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201400137     Document Type: Article

References (53)

1. S. A. Abraham, D. N. Waterhouse, D. L. Mayer, R. P. Cullis, D. T. Madden, B. M. Bally, in: The liposomal formulation of doxorubicin (Ed: D. Nejat), Methods in Enzymology.: Academic Press, 2005, pp 71-97.
2. K. L. Hennenfent, R. Govindan, Ann. Oncol. 2006, 17, 735.
3. K. Gardikis, C. Tsimplouli, K. Dimas, M. Micha-Screttas, C. Demetzos, Int. J. Pharm. 2010, 402, 231.
4. K. Gardikis, D. Fessas, M. Signorelli, K. Dimas, C. Tsimplouli, M. Ionov, C. Demetzos, J. Nanosci. Nanotechnol. 2011, 11, 3764.
5. M. T. Mueller, P. C. Hermann, J. Witthauer, B. Rubio-Viqueira, S. F. Leicht, S. Huber, W. J. Ellwart, M. Mustafa, P. Bartenstein, G. J. D'Haese, M. H. Schoenberg, F. Berger, K. W. Jauch, M. Hidalgo, C. Heeschen, Gastroenterology 2009, 137, 1102.
6. Y. Matsumura, Jpn. J. Clin. Oncol. 2008, 38, 793.
7. Y. Matsumura, K. Kataoka, Cancer Sci. 2009, 100, 572.
8. K. K. Upadhyay, H. G. Agrawal, C. Upadhyay, C. Schatz, J. F. Le Meins, A. Misra, S. Lecommandoux, Crit. Rev. Ther. Drug Carrier Syst. 2009, 26, 157.
9. L. L. Yang, X. H. Wu, F. Liu, Y. R. Duan, M. S. Li, Pharm. Res. 2009, 26, 2332.
10. P. L. Kuo, W. J. Liang, Y. F. Wang, J. Polym. Sci., Part A: Polym. Chem. 2003, 41, 1360.
11. P. L. Kuo, W. J. Liang, F. Y. Wang, Colloid Polym. Sci. 2006, 284, 435.
12. D. E. Disher, F. Ahmed, Annu. Rev. Biomed. Eng. 2006, 8, 323.
13. F. Ahmed, R. I. Pakunlu, A. Brannan, F. Bates, T. Minko, D. E. Discher, J. Controlled Release 2006, 28, 150.
14. F. Chécot, A. BrÛlet, J. Oberdisse, Y. Gnanou, O. Mondain-Monval, S. Lecommandoux, Langmuir 2005, 21, 4308.
15. Y. Bae, N. Nishiyama, K. Kataoka, Bioconjugate Chem. 2007, 18, 1131.
16. H. Iatrou, H. Frielinghaus, S. Hanski, N. Ferderigos, J. Ruokolainen, O. Ikkala, D. Richter, J. Mays, N. Hadjichristidis, Biomacromolecules 2007, 8, 2173.
17. M. Massignani, C. LoPresti, A. Blanazs, J. Madsen, S. P. Armes, A. L. Lewis, G. Battaglia, Small 2009, 5, 2424.
18. A. Blanazs, M. Massignani, G. Battaglia, S. P. Armes, A. J. Ryan, Adv. Funct. Mater. 2009, 19, 2906.
19. G. Liu, S. Mab, S. Li, R. Cheng, F. Meng, H. Liu, Z. Zhong, Biomaterials 2010, 31, 7575.
20. Y. Du, W. Chen, M. Zheng, F. Meng, Z. Zhong, Biomaterials 2012, 33, 7291.
21. X. Wang, H. Sun, F. Meng, R. Cheng, C. Deng, Z. Zhong, Biomacromolecules 2013, 14, 2873.
22. C. Deng, J. Wu, R. Cheng, F. Meng, H. Klok, Z. Zhong, Prog. Polym. Sci. 2014, 39, 330.
23. N. Hadjichristidis, H. Iatrou, S. Pispas, M. Pitsikalis, J. Polym. Sci., Part A 2000, 38, 3211.
24. T. Aliferis, H. Iatrou, N. Hadjichristidis, Biomacromolecules 2004, 5, 1653.
25. C. Matsingou, S. Hatziantoniou, A. Georgopoulos, K. Dimas, A. Terzis, C. Demetzos, Chem. Phys. Lipids 2005, 138, 1.
26. NCI, Biological Testing Branch, cute Toxicity Determination: http://dtp.nci.nih.gov/branches/btb/acute-tox.html (accessed November 2013).
27. E. Cukierman, D. R. Khan, Biochem. Pharmacol. 2010, 80, 762.
28. V. P. Torchilin, J. Controlled Release 2001, 73, 137.
29. V. P. Torchilin, Cell Mol. Life Sci. 2004, 61, 2549.
30. R. Haag, F. Kratz, Angew. Chem. Int. Ed. 2006, 45, 1198.
31. B. A. Pfeifer, J. A. Burdick, R. Langer, Biomaterials 2005, 26, 117.
32. S. M. Moghimi, A. C. Hunter, J. C. Murray, Pharmacol. Rev. 2001, 53, 283.
33. D. E. Discher, A. Eisenberg, Science 2002, 297, 967.
34. J. F. Le Meins, O. Sandre, S. Lecommandoux, Eur. Phys. J. E Soft Matter 2011, 34, 1.
35. F. Meng, Z. Zhong, J. Phys. Chem. Lett. 2011, 2, 1533.
36. J. S. Lee, J. Feijen, J. Controlled Release 2012, 161, 473.
37. K. L. Thompson, P. Chambon, R. Versber, S. P. Armes, J. Am. Chem. Soc. 2012, 134, 12450.
38. M. Marguet, L. Edembe, S. Lecommandoux, Angew. Chem. Int. Ed. 2012, 51, 1173.
39. J. C. M. Lee, H. Bermudez, B. M. Discher, M. A. Sheehan, Y. Y. Won, F. S. Bates, D. E. Discher, Biotechnol. Bioeng. 2001, 73, 135.
40. F. Meng, G. H. M. Engbers, J. Feijen, J. Controlled Release 2005, 101, 187.
41. H. Bermudez, A. K. Brannan, D. A. Hammer, F. S. Bates, D. E. Discher, Macromolecules 2002, 35, 8203.
42. P. J. Photos, L. Bacakova, B. Discher, F. S. Bates, D. E. Discher, J. Controlled Release 2003, 90, 323.
43. J. H. Beijnen, O. A. G. J. van der Houwen, W. J. M. Underberg, Int. J. Pharm. 1986, 32, 123.
44. M. J. H. Janssen, D. J. A. Crommelin, G. Storm, A. Hulshoff, Int. J. Pharm. 1985, 23, 1.
45. S. K. Dordunoo, H. M. Burt, Int. J. Pharm. 1996, 133, 191.
46. C. Sanson, C. Schatz, J. F. Le Meins, A. Soum, J. Thévenot, E. Garanger, S. Lecommandoux, J. Controlled Release 2010, 147, 428.
47. K. Kataoka, T. Matsumoto, M. Yokoyama, T. Okano, Y. Sakurai, S. Fukushima, K. Okamoto, G. S. Kwon, J. Controlled Release 2000, 64, 143.
48. Z. Du, S. Pan, Q. Yu, Y. Li, Y. Wen, W. Zhang, M. Feng, C. Wu, Colloids Surf. A: Physicochem. Eng. Aspects 2010, 353, 140.
49. C. Wang, Y. J. Wang, Y. J. Wang, M. Fan, F. Luo, Z. Y. Qian, Int. J. Pharm. 2011, 414, 251.
50. L. Shuliang, B. Byrne, J. E. Welsh, A. F. Palmer, Biotechnol. Prog. 2007, 23, 278.
51. W. B. Titlow, C. H. Lee, C. Ryou, J. Microbiol. Biotechnol. 2013, 23, 1015.
52. L. J. J. Arnold, A. Dagan, J. Gutheil, N. O. Kaplan, Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 3246.
53. M.W. Hatton, E. Regoeczi, Biochim. Biophys. Acta 1975, 379, 504.